Other primary hyperaldosteronism
ICD-10 E26.09 is a billable code used to indicate a diagnosis of other primary hyperaldosteronism.
Other primary hyperaldosteronism refers to conditions characterized by excessive production of aldosterone from the adrenal glands, leading to hypertension and electrolyte imbalances. This condition can arise from various adrenal disorders, including adrenal adenomas, bilateral adrenal hyperplasia, or other rare causes. Aldosterone plays a crucial role in regulating sodium and potassium levels in the body, and its overproduction can result in sodium retention, potassium loss, and increased blood volume, ultimately causing hypertension. Patients may present with symptoms such as muscle weakness, fatigue, and headaches due to electrolyte imbalances. Diagnosis typically involves measuring plasma aldosterone levels, plasma renin activity, and conducting imaging studies to identify adrenal abnormalities. Treatment options may include mineralocorticoid receptor antagonists, surgical intervention for adrenal tumors, or lifestyle modifications to manage hypertension. Accurate coding is essential for proper reimbursement and to reflect the complexity of the patient's condition.
Detailed endocrine evaluation, including hormone levels and imaging studies.
Patients presenting with hypertension and hypokalemia, requiring assessment for hyperaldosteronism.
Endocrinologists must ensure comprehensive documentation of all hormonal assays and imaging results to support the diagnosis.
Thorough history and physical examination, including blood pressure readings and electrolyte levels.
Management of patients with resistant hypertension and suspected hyperaldosteronism.
Internists should document any referrals to endocrinology or nephrology for further evaluation.
Used to confirm diagnosis of hyperaldosteronism.
Document the reason for the test and the patient's clinical presentation.
Endocrinologists should ensure that lab results are clearly linked to the diagnosis.
Common symptoms include hypertension, muscle weakness, fatigue, and frequent urination due to electrolyte imbalances.
Diagnosis typically involves measuring plasma aldosterone levels, plasma renin activity, and imaging studies to identify adrenal abnormalities.
Treatment may include mineralocorticoid receptor antagonists, surgical removal of adrenal tumors, or lifestyle modifications to manage hypertension.
